Author

Garrett R. Gibson

Observed names: Garrett Gibson, Garrett R Gibson

Institution: Children’s Mercy Research Institute

Observed institution: Children’s Mercy Research Institute

ORCID: 0009-0001-1881-899X

Observed ORCID: 0009-0001-1881-899X

OpenAlex ID: A5114595059

Current Landscape of Preclinical Models for Pediatric Gliomas: Clinical Implications and Future Directions

2025 · Syed M. Faisal, Monika Yadav, et al. · Cancers · 8

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models

2025 · Melanie Schoof, Tuyu Zheng, et al. · Nature Genetics · 5

Dddr-35. Therapeutic Strategies for Diffuse Midline Glioma: Insights From High-throughput Combination Drug and Radiation Sensitization Screening

2024 · Syed M Faisal, Monika Yadav, et al. · Neuro-Oncology · 1

248 Potent anti-tumor efficacy of B7-H3 CAR-T cells in H3G34 mutant diffuse hemispheric gliomas

2026 · Monika Yadav, David Akhavan, et al. · Journal for ImmunoTherapy of Cancer

IMMU-23 Locoregional B7-H3 CAR T Cell Therapy Elicits Potent Antitumor Immunity and Durable Responses in Preclinical Models of H3G34R/V-Mutant Diffuse Hemispheric Glioma: Rationale for Clinical Translation

2026 · Monika Yadav, David David Akhavan2, et al. · Neuro-Oncology

Potent antitumor preclinical efficacy of B7-H3 chimeric antigen receptor (CAR) T cells in H3G34-mutant, diffuse hemispheric glioma

2026 · David Akhavan, Monika Yadav, et al. · Neuro-Oncology

Abstract 3153: High-throughput identification of radiosensitizers and synergistic drug combinations with potent therapeutic efficacy against diffuse midline glioma

2025 · Syed M. Faisal, Monika Yadav, et al. · Cancer Research

Works count: 7

Citation count: 14

H-index: 2

I10-index: